Background The role of ivermectin in the treatment of COVID-19 is still under debate, yet the
drug has been widely used in some parts of the world, as shown by impressive market data …

Since the first reports from December 2019, COVID-19 caused an overwhelming global
pandemic that has affected 223 countries, seriously endangering public health and creating …

Tocilizumab is an interleukin (IL)‐6 receptor inhibitor that has been proposed as a
therapeutic agent for treating coronavirus disease 2019 (COVID‐19). The aim of this …

Simple Summary Exploring the possibility of using well-known marketed drugs in new
therapeutic indications, commonly known as drug repurposing, offers certain advantages …

Objective: This review was performed to compare the efficacy and safety among hospitalized
patients with COVID-19 who received baricitinib and those who received tocilizumab …

All authors (SG Rothrock, KD Weber, M. Barneck, PA Giordano) were involved in conception
of study, design of the study, data collection and abstraction, drafting and revision of the …

Ever since it was first reported in Wuhan, China, the coronavirus-induced disease of 2019
(COVID-19) has become an enigma of sorts with ever expanding reports of direct and …

Numerous treatments exist for COVID-19, the illness caused by SARS-CoV-2 virus, although
most are not well established; among these are several small molecule antiviral agents …

Background: The first case of coronavirus disease 2019 (COVID-19) in Poland was reported
on 4 March 2020. We aim to compare the clinical course and outcomes of patients …

The detection of pharmaceutical compounds in extremely low concentrations remains a
challenge despite recent advancements in electrochemical sensing. In this study, a green …